Skip to main content

Janux Therapeutics, Inc.

JANX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001817713

No open-market purchases or sales by Janux Therapeutics, Inc. insiders were filed in the last 90 days; 197 institutions reported holding it in 13F filings for Q2 2026, worth $933.4M in total; no superinvestor holds it.

13F holders, Q1 2023

Institutional positions in Janux Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
48
−2 vs. Q4 2022
Shares held
30.5M
+1.59M (+5.5%) vs. Q4 2022
Total value
$369.5M
−$11.8M (−3.1%) vs. Q4 2022
New holders
8
22 more added
Sold out
10
11 more reduced

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting JANX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 48 institutions
Q1 2021: 0 institutionsQ2 2021: 30 institutionsQ3 2021: 45 institutionsQ4 2021: 46 institutionsQ1 2022: 47 institutionsQ2 2022: 44 institutionsQ3 2022: 49 institutionsQ4 2022: 50 institutionsQ1 2023: 48 institutionsQ2 2023: 54 institutionsQ3 2023: 57 institutionsQ4 2023: 64 institutionsQ1 2024: 121 institutionsQ2 2024: 155 institutionsQ3 2024: 160 institutionsQ4 2024: 216 institutionsQ1 2025: 181 institutionsQ2 2025: 174 institutionsQ3 2025: 174 institutionsQ4 2025: 176 institutionsQ1 2026: 190 institutionsQ2 2026: 197 institutions
Value heldQ1 2023: $369.5M
Q1 2021: $0Q2 2021: $614.5MQ3 2021: $571.2MQ4 2021: $541.6MQ1 2022: $407.1MQ2 2022: $353.0MQ3 2022: $400.3MQ4 2022: $381.3MQ1 2023: $369.5MQ2 2023: $362.1MQ3 2023: $354.0MQ4 2023: $359.5MQ1 2024: $1.59BQ2 2024: $1.87BQ3 2024: $2.07BQ4 2024: $3.43BQ1 2025: $1.81BQ2 2025: $1.51BQ3 2025: $1.59BQ4 2025: $860.0MQ1 2026: $827.8MQ2 2026: $933.4M
Institutions holding JANX and their total value by quarter
QuarterHoldersValue
Q2 2026197$933.4M
Q1 2026190$827.8M
Q4 2025176$860.0M
Q3 2025174$1.59B
Q2 2025174$1.51B
Q1 2025181$1.81B
Q4 2024216$3.43B
Q3 2024160$2.07B
Q2 2024155$1.87B
Q1 2024121$1.59B
Q4 202364$359.5M
Q3 202357$354.0M
Q2 202354$362.1M
Q1 202348$369.5M
Q4 202250$381.3M
Q3 202249$400.3M
Q2 202244$353.0M
Q1 202247$407.1M
Q4 202146$541.6M
Q3 202145$571.2M
Q2 202130$614.5M
Q1 20210$0

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding Janux Therapeutics, Inc.; share changes are against Q4 2022.

Institutions holding JANX in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Ra Capital Management, L.P.8,670,644$104.9M2.38%00.0%Unchanged
FMR LLC5,140,644$62.2M0.01%−465,216−8.3%Reduced
EcoR1 Capital, LLC3,838,486$46.4M1.50%+2,417,167+170.1%Added
OrbiMed Advisors LLC2,836,386$34.3M0.68%00.0%Unchanged
Janus Henderson Group PLC1,869,076$22.6M0.01%+31,285+1.7%Added
Citadel Advisors LLC1,853,026$22.4M0.02%−1,785−0.1%Reduced
BVF Inc1,585,677$19.2M0.70%+115,343+7.8%Added
BlackRock Inc.1,134,645$13.7M0.00%+31,590+2.9%Added
Adage Capital Partners GP, L.L.C.900,000$10.9M0.02%+198,934+28.4%Added
Vanguard Group Inc772,655$9.35M0.00%+18,035+2.4%Added
Samsara BioCapital, LLC360,414$4.36M0.90%00.0%Unchanged
Geode Capital Management, LLC354,585$4.29M0.00%+14,788+4.4%Added
State Street Corp298,629$3.61M0.00%+15,519+5.5%Added
Northern Trust Corp139,971$1.69M0.00%+243+0.2%Added
Woodline Partners LP137,300$1.66M0.02%−368,064−72.8%Reduced
JPMorgan Chase & Co129,657$1.57M0.00%+25,874+24.9%Added
Vident Investment Advisory, LLC55,483$671.3K0.02%−2,031−3.5%Reduced
Bank of New York Mellon Corp53,091$642.4K0.00%−414−0.8%Reduced
DekaBank Deutsche Girozentrale49,500$574.0K0.00%00.0%Unchanged
Nuveen Asset Management, LLC45,903$555.0K0.00%−14,814−24.4%Reduced
Charles Schwab Investment Management Inc45,392$549.2K0.00%−2,298−4.8%Reduced
Millennium Management LLC34,103$413.0K0.00%−5,807−14.6%Reduced
Morgan Stanley33,504$405.4K0.00%+16,020+91.6%Added
Swiss National Bank27,000$326.7K0.00%+27,000New
Rhumbline Advisers26,849$325.0K0.00%+1,158+4.5%Added
Bank of America Corp23,737$287.2K0.00%+5,239+28.3%Added
California State Teachers Retirement System17,331$209.7K0.00%+10,480+153.0%Added
New York State Common Retirement Fund13,248$160.3K0.00%+13+0.1%Added
Squarepoint Ops LLC13,167$159.3K0.00%+13,167New
Susquehanna International Group, LLP12,728$154.0K0.00%+12,728New
State of Wisconsin Investment Board11,555$139.8K0.00%+11,555New
MetLife Investment Management10,614$128.4K0.00%00.0%Unchanged
Deutsche Bank AG10,458$126.5K0.00%+2,245+27.3%Added
Barclays PLC8,904$107.7K0.00%+4,296+93.2%Added
American International Group, Inc.8,282$100.2K0.00%+164+2.0%Added
Legal & General Group Plc4,710$57.0K0.00%+2,968+170.4%Added
Tower Research Capital LLC (TRC)3,344$40.0K0.00%+2,003+149.4%Added
Wells Fargo & Company3,085$37.3K0.00%+3,085New
Amalgamated Bank1,784$22.0K0.00%−398−18.2%Reduced
Russell Investments Group, Ltd.1,532$18.5K0.00%+1,532New
Ameritas Investment Partners, Inc.1,014$12.3K0.00%00.0%Unchanged
Metropolitan Life Insurance Co1,004$12.1K0.00%−378−27.4%Reduced
Royal Bank of Canada960$12.0K0.00%−1,221−56.0%Reduced
UBS Group AG841$10.2K0.00%+628+294.8%Added
Citigroup Inc559$6.76K0.00%+162+40.8%Added
Tucker Asset Management LLC250$3.02K0.00%+250New
Crewe Advisors LLC115$1.39K0.00%00.0%Unchanged
US Bancorp90$1.09K0.00%+90New
5AM Venture Management, LLC0$00.00%−446,266−100.0%Sold out
Ergoteles LLC0$00.00%−31,563−100.0%Sold out
Parkwood LLC0$00.00%−21,469−100.0%Sold out
Goldman Sachs Group Inc0$00.00%−14,603−100.0%Sold out
HRT Financial LP0$00.00%−12,298−100.0%Sold out
SG Americas Securities, LLC0$00.00%−7,902−100.0%Sold out
TCI Wealth Advisors, Inc.0$00.00%−91−100.0%Sold out
Simplex Trading, LLC0$00.00%−100−100.0%Sold out
McElhenny Sheffield Capital Management, LLC0$00.00%−17−100.0%Sold out
Credit Suisse AG0$00.00%−1−100.0%Sold out